OUR COMPANY
Built to make
expertise go further.
Redefine Surgery brings together medical device experience, engineering and surgeon insight to build the intelligence layer for open surgery.
OUR MISSION
Transfer mastery.
Amplify human skill.
REDEFINE SURGERY / OUR COMPANY
Our mission is for AI to learn from the world’s best surgeons and transfer their mastery to every operating room by the end of this decade.
Founded in 2023 by Peter Verrillo, Ignacio Tzoumas and Stephen Potter, Redefine is developing a platform that connects surgical perception, expert knowledge and physical tools. Our category is Collaborative Surgical Intelligence: technology designed to work with the surgeon.
OUR CONVICTION
Physical AI will create the greatest value where human expertise matters most.
WE’RE APPLYING IT TO SURGERY.
THE FOUNDING TEAM
Experience across
devices and technology.
Peter Verrillo
CEO & CO-FOUNDER
Leads the company’s vision, strategy and medical device partnerships, drawing on more than two decades in orthopedic and surgical technology.
Ignacio Tzoumas
COO & CO-FOUNDER
Leads operations and helps translate the company’s technology and partnership strategy into an executable business.
Working with surgeons, engineers and medical device partners to turn a broad vision into focused development programs.
Stephen Potter
CTO & CO-FOUNDER
Leads the technical direction of the platform, connecting computer vision, software and physical systems.
HOW WE BUILD
Clinical need at the center.
01 / SURGEON-LED
Start with the work.
Understand the procedure, the decisions and the constraints before choosing a technology or form factor.
02 / PARTNER-FIRST
Build for integration.
Create infrastructure that can become part of a partner’s product strategy, clinical workflow and distribution network.
03 / EVIDENCE-DRIVEN
Earn the next step.
Develop capabilities through focused technical evaluation, workflow feedback and application-specific validation
A GROWING FOUNDATION
Backed by people
who know surgery.
Our public pre-seed announcement reports $10 million raised, backed predominantly by surgeon investors. Catalyst OrthoScience joins as our Founding Partner for shoulder arthroplasty.
Redefine is also part of the Techstars Boston community. The company’s progress reflects a shared conviction among clinicians, industry leaders and builders that surgery needs an intelligence layer.
BUILD WITH US
Bring your perspective
to a consequential problem.
We welcome conversations with engineers, researchers, clinicians and industry collaborators who want to help build Physical AI for surgery.